Compare EBON & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EBON | VTGN |
|---|---|---|
| Founded | 2010 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.5M | 21.8M |
| IPO Year | 2020 | 2014 |
| Metric | EBON | VTGN |
|---|---|---|
| Price | $2.45 | $0.58 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $0.90 |
| AVG Volume (30 Days) | 4.7K | ★ 975.0K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ N/A | N/A |
| Revenue This Year | N/A | $93.93 |
| Revenue Next Year | N/A | $243.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.30 | $0.43 |
| 52 Week High | $5.90 | $5.14 |
| Indicator | EBON | VTGN |
|---|---|---|
| Relative Strength Index (RSI) | 35.84 | 36.44 |
| Support Level | $2.30 | $0.50 |
| Resistance Level | $3.76 | $0.60 |
| Average True Range (ATR) | 0.23 | 0.05 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 20.85 | 74.46 |
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.